Michael J. Szymonifka
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael J. Szymonifka.
Chemistry & Biology | 2009
Joann Huber; Robert G.K. Donald; Sang Ho Lee; Lisa Wang Jarantow; Michael J. Salvatore; Xin Meng; Ronald E. Painter; Russell Onishi; James Occi; Karen Dorso; Katherine Young; Young Whan Park; Stephen Skwish; Michael J. Szymonifka; Tim S. Waddell; Lynn Miesel; John W. Phillips; Terry Roemer
Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial and community-acquired pathogen for which few existing antibiotics are efficacious. Here we describe two structurally related synthetic compounds that potentiate beta-lactam activity against MRSA. Genetic studies indicate that these agents target SAV1754 based on the following observations: (i) it has a unique chemical hypersensitivity profile, (ii) overexpression or point mutations are sufficient to confer resistance, and (iii) genetic inactivation phenocopies the potentiating effect of these agents in combination with beta-lactams. Further, we demonstrate these agents inhibit peptidoglycan synthesis. Because SAV1754 is essential for growth and structurally related to the recently reported peptidoglycan flippase of Escherichia coli, we speculate it performs an analogous function in S. aureus. These results suggest that SAV1754 inhibitors might possess therapeutic potential alone, or in combination with beta-lactams to restore MRSA efficacy.
Tetrahedron Letters | 1989
Michael J. Szymonifka; James V. Heck
Abstract The preparation of 4-carbomethoxy-1,2-thiazetidine-1,1-dioxides from carbomethoxymethanesulfonyl chloride and imines is described.
Tetrahedron Letters | 1995
Michael J. Szymonifka; Kevin T. Chapman
Abstract The preparation of magnetite-impregnated polymeric supports for use in solid phase organic synthesis is described.
Tetrahedron Letters | 1982
James V. Heck; Michael J. Szymonifka; Burton G. Christensen
Abstract The title compounds were synthesized in ten steps using as key ring-forming reactions an imine-acid chloride cyclization and a rhodium-mediated carbenoid insertion.
Tetrahedron Letters | 1989
Michael J. Szymonifka; James V. Heck
Abstract The reaction of 2-unsubstituted 1,2-thiazetidine-1,1-dioxides with n-butyllithium affords dianions which react with a variety of electrophiles. Selective mono- and dialkylation is readily accomplished.
Bioorganic & Medicinal Chemistry Letters | 2005
Susan D. Aster; Donald W. Graham; Divya Kharbanda; Gool F. Patel; Mitree M. Ponpipom; Gina M. Santorelli; Michael J. Szymonifka; Steven S. Mundt; Kashmira Shah; Marty S. Springer; Rolf Thieringer; Anne Hermanowski-Vosatka; Samuel D. Wright; Jianying Xiao; Hratch J. Zokian; James M. Balkovec
Archive | 1992
James V. Heck; William J. Leanza; Ronald W. Ratcliffe; Thomas N. Salzmann; Robert R. Wilkening; Michael J. Szymonifka; Kothandaraman Shankaran
Bioorganic & Medicinal Chemistry Letters | 2005
Weiguo Liu; Steve Chen; James F. Dropinski; Lawrence F. Colwell; Michael Robins; Michael J. Szymonifka; Nancy S. Hayes; Neelam Sharma; Karen L. MacNaul; Melba Hernandez; Charlotte Burton; Carl P. Sparrow; John G. Menke; Sheo B. Singh
Bioorganic & Medicinal Chemistry Letters | 2007
Hong C. Shen; Michael J. Szymonifka; Divya Kharbanda; Qiaolin Deng; Ester Carballo-Jane; Kenneth K. Wu; Tsuei-Ju Wu; Kang Cheng; Ning Ren; Tian-Quan Cai; Andrew K.P. Taggart; Junying Wang; Xinchun Tong; M. Gerard Waters; Milton L. Hammond; James R. Tata; Steven L. Colletti
Archive | 1992
James V. Heck; William J. Leanza; Ronald W. Ratcliffe; Thomas N. Salzmann; Kothandaraman Shankaran; Michael J. Szymonifka; Robert R. Wilkening